12/10/2008 | CV | Market Commentary: Convertibles mostly steady to firmer: Kodak holds up; AmeriCredit adds; Ford, GM mixed; Nortel drops
|
12/4/2008 | CV | Market Commentary: Prudential longer paper gains; ImClone weaker; Advanced Micro mostly quiet on lowered outlook
|
11/26/2008 | CV | ImClone to redeem 1.375% convertible notes due 2024 in connection with Eli Lilly merger
|
11/11/2008 | CV | ImClone considers refinancing 1.375% convertibles ahead of May put
|
10/1/2008 | CV | Market Commentary: Convertible price dislocations plague market; Ford, Amgen off; ImClone little moved; Fannie Mae at parity
|
7/31/2008 | CV | Market Commentary: ImClone gains on Bristol-Myers offer; Amylin rises on M&A chatter; Hologic lower after earnings
|
6/2/2008 | CV | Market Commentary: Financials slip, but not badly, on Wachovia ouster, S&P downgrade; Coal names higher; ImClone quiet
|
9/11/2007 | CV | Market Commentary: Countrywide continues slide; Thornburg up; ImClone drug sparks investor hopes; Nabi trades big, if not much
|
7/12/2007 | CV | Market Commentary: Newmont strikes gold; Kendle continues strong; Molson Coors seen refreshing; Huntsman drops a peg
|
6/7/2007 | CV | Market Commentary: Shuffle Master drops on earnings; ImClone slips on downgrade; Wednesday's pains hurt outrights more
|
4/12/2007 | CV | Market Commentary: TriZetto gains in start; MedImmune surges on buyer search; RAIT, Franklin deals seen with subprime risks
|
10/25/2006 | CV | Market Commentary: ImClone slips on board change; Mills gains on offer; United Therapeutics improves; GM slips
|
10/10/2006 | CV | Market Commentary: Nabors gains on buyout rumors; ImClone flat; Amkor climbs with credit; Priceline.com gains on tender
|
10/4/2006 | CV | Market Commentary: ImClone higher on buyout talk; World Acceptance jumps on debut; Ford gains, GM slips on ceased talks
|
9/28/2006 | CV | Market Commentary: Amkor up on revised offer; Nabi gains on sale hopes; ImClone rides stock rally; Brandywine quiet in gray
|
9/27/2006 | CV | Market Commentary: BearingPoint, Amkor slip on default woes; Red Hat falls outright with earnings; Brandywine plans deal
|
9/19/2006 | CV | Market Commentary: ImClone slips on lost patent; Yahoo drops with sales warning; First Industrial, BioMed launch REIT deals
|
9/11/2006 | CV | Market Commentary: Scottish Re gains on buyout bids; ImClone rallies with stock; AmeriCredit, Bristow lead wave of new deals
|
8/10/2006 | CV | Market Commentary: Andrew, ImClone fall on failed buyouts; BRE, Digital Realty climb on debuts; Cephalon firm as drug flops
|
7/24/2006 | CV | Market Commentary: Amazon.com better ahead of results; ImClone gains on buyout hopes; Amylin drops as call hurdle topples
|
7/20/2006 | BTCV | ImClone reports Q2 net income of $37.2 million; Erbitux sales of $172.8 million
|
7/7/2006 | CV | Market Commentary: PMC-Sierra trips on outlook, CFO's resignation; General Motors up on meeting; Par Pharmaceutical eases
|
2/2/2006 | CV | Market Commentary: ImClone steady despite lack of Bristol-Myers interest; Teva under pressure; Omnicare edges lower
|
1/27/2006 | BTCV | New Issue: Barclays sells $2 million 11.5% exchangeables linked to ImClone
|
1/24/2006 | CV | Market Commentary: ImClone convertibles jump on potential sale; focus shifts to proposed NRG, UAG deals
|
1/10/2006 | CV | Barclays plans issue of 11.5% exchangeables linked to ImClone
|
11/7/2005 | CV | Market Commentary: Northwest, AMR higher as oil declines; Genzyme eases but Cephalon edges higher
|
11/3/2005 | CV | Market Commentary: Chesapeake, Qwest trade higher; Abgenix, Amgen rise, but ImClone lower; SFBC plunges
|
7/29/2005 | BTCV | New Issue: Wachovia prices $8.5 million 15.5% trigger Capitals linked to ImClone
|
7/26/2005 | CV | Market Commentary: GM up on GMAC financing; Ford, DaimlerChrysler mixed; Manor Care, Barnes at bat; Fairmont Hotels falls
|
6/8/2005 | CV | Market Commentary: ImClone, Impax brighten as convertible players eye firmer market; GM extends gains
|
5/26/2005 | CV | Market Commentary: Ford, GM better on short covering; airlines also firmer; techs rally but Computer Associates off after bell
|
4/13/2005 | CV | Market Commentary: Ford picks up buyers as selling in supplier Lear accelerates; Imclone crushed on delay; Goodyear skids
|
7/21/2004 | CV | Market Commentary: Ocwen getting large outright orders; Lucent, telecom zeal fades; Delta skids off highs
|
7/16/2004 | CV | Market Commentary: Delta, Northwest lower ahead of earnings; Caesars steady; Amerada Hess, oil paper zoom
|
5/19/2004 | CV | ImClone calls 51/2% convertibles
|
5/12/2004 | CV | Market Commentary: CV Therapeutics bid at 100.375 in gray market; Pixelworks still; OSI Pharma, ImClone up sharply
|
5/5/2004 | CV | Market Commentary: Oscient Pharmaceuticals hits par 1/8 bid on first day of trading
|
5/4/2004 | CV | New Issue: ImClone upsized $500 million mandatory convertible yields 1.375%, up 42%
|
5/4/2004 | CV | Market Commentary: ImClone trades off gray levels; five new deals surface after Fed leaves rates alone
|
5/3/2004 | CV | ImClone upsized $500 million convertible talk revised intraday to 1.375%-1.5%, up 38%-42%
|
5/3/2004 | CV | Market Commentary: ImClone bid at 102.75 even after terms tightened; Oscient emerges; Albertson's at bat; Conseco Thursday
|
4/19/2004 | CV | Market Commentary: Northrop slammed after WSJ report; CKE, American Tower, Crown Castle up on tightening
|
3/4/2004 | CV | Market Commentary: EDS up on IBM bid buzz; Covad offered at plus 2 points in gray; Calpine firms on deal revival talk
|
2/13/2004 | CV | Market Commentary: Adelphia bonds Earthbound, lose 6 points; Sirius, new paper active but slip to below par levels
|
2/12/2004 | CV | Market Commentary: Buyers propel new AMR convert; Bristol-Myers up on Erbitux news; Incyte trades at par in gray market
|
11/24/2003 | CV | Market Commentary: Market hunts for Thanksgiving deal, Ciber answers the call with small issue; trading flow low
|
4/11/2003 | CV | Market Commentary: Market slow, slower ahead of short week, anticipated earnings deluge
|
3/31/2003 | CV | Market Commentary: Market tiptoes into earnings season with anxiety, weighed down by uncertainty of war length
|
3/3/2003 | CV | Market Commentary: Inco prices $400 million, Watson launches quickie; Capital One dives on CFO departure
|
2/19/2003 | CV | Market Commentary: New deals boost trading activity while stocks retreat
|
1/30/2003 | CV | Deutsche sees 9 biotech issues highly probable for distressed exchange
|
11/14/2002 | CV | Market Commentary: Buyers emerge from sidelines to bid up high delta, gamma issues
|
9/24/2002 | CV | Market Commentary: Ballooning credit spreads weigh but drugmakers gain on buying
|
8/20/2002 | CV | Market Commentary: New deals stimulate players; retailers find bargain hunters
|
8/19/2002 | CV | Market Commentary: OSI, ImClone wounded; retailers build on strong surge at Lowe's
|
8/7/2002 | CV | Market Commentary: Convertibles tick up along with stocks, trading spotty still but volumes gain
|
6/19/2002 | CV | Market Commentary: Players sit out stock sell-off, dragging convertibles along
|
6/13/2002 | CV | Market Commentary: Tyco, ImClone rebound but convertibles tank overall as stocks retreat
|
6/12/2002 | CV | Market Commentary: Convertibles lag gain seen in stocks; Tyco, CMS, ImClone hamper market
|
5/22/2002 | CV | Market Commentary: Adelphia firms on buzz of Rigas deal; Berkshire surprises with overnighter
|
5/20/2002 | CV | Market Commentary: Buyers emerge for downtrodden Adelphia, Lucent, energy traders; biotechs fall amid profit taking
|
4/10/2002 | CV | JPMorgan recommends 9 biotech convertibles for yield, capital appreciation, relative value
|
3/21/2002 | CV | Convertibles gain as buyers emerge, PDLI clips slide
|
3/8/2002 | CV | Market Commentary: Convertibles gain on Nasdaq strength; Alpharma drops
|
3/7/2002 | CV | Market Commentary: Convertibles stall with stocks; oils, financials gain
|
3/1/2002 | CV | Market Commentary: Convertibles bounce but new paper lags
|
2/27/2002 | CV | Market Commentary: Convertibles mixed, new deals at center stage
|
1/25/2002 | CV | Market Commentary: Convertibles flat as braces for busy week ahead
|
1/18/2002 | CV | Market Commentary: Convertibles retreat, healthcare issues hit hard, Tyco takes wild ride
|
1/9/2002 | CV | Market Commentary: Convertibles lower on extended profit taking as new deals emerge
|
1/7/2002 | CV | Market Commentary: Convertibles sink on profit taking as stocks retreat
|
1/2/2002 | CV | Market Commentary: Convertibles slightly higher but thin post-holiday volume persist
|
12/12/2001 | CV | Market Commentary: Convertible market broadly mixed on Enron hype, new issues,
|